Tizanidine Tablet
Product Images NDC 70518-3181

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 70518-3181). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a package of TiZANidine tablets. Each package contains 60 tablets, each of which is 2 mg. The tablets are manufactured by Sun Pharma in Cranbury, N.J. The NDC number for this medication is 70518-3181-00. The lot number and expiration date are not provided in the text. TiZANidine tablets cannot be substituted with TiZANidine capsules. Storage instructions are provided that suggest keeping the medication at room temperature. The packaging has been repackaged by RemedyRepack Inc. and should be kept out of reach of children.*
FDA Label Image

Tizanidine-1 (Tizanidine 1)

FDA Label Image

Tizanidine-2 (Tizanidine 2)

FDA Label Image

Tizanidine-3 (Tizanidine 3)

FDA Label Image

Tizanidine-4 (Tizanidine 4)

Tizanidine-4 (Tizanidine 4)
This appears to be a portion of a medical study or report discussing the improvement in Ashworth score with a mean dose of 26.8 mg. The text indicates different stages in the study, including the end of titration at week 3 and end of maintenance at week 7, as well as an endpoint analyzed through the "Last Observation Carried Forward" method.*
FDA Label Image

Tizanidine 2mg 70518 3181 01

Tizanidine 2mg 70518 3181 01
This is a description of a medication called tiZANidine. The medication is available in tablet form with an expiration date and lot number specified. The manufacturing information is also given, with the medication being made by Sun Pharma, located in Cranbury, N.J. The directions for use are included in the package insert. There is a warning that the tiZANidine tablets should not be substituted for tiZANidine capsules. The medication should be kept out of the reach of children and stored at a temperature between 20-26°C, with excursions permitted to 15-30°C. The medication has been repackaged by RemedyRepack Inc. in Indiana, PA and is only available by prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.